Palacio de Convenciones de la Habana, Cuba, del 03 al 07 de diciembre de 2018
Inicio / Convocatoria

Conferencistas Confirmados

  • Gordon L. Amidon, PhD
  • Maria del Val (Marival)  Bermejo


GORDON L. AMIDON, PhD

Charles R. Walgreen, Jr., Prof. of Pharmacy

Prof. of Pharmaceutical Sciences

College of Pharmacy, The University of Michigan

Ann Arbor, Michigan USA

Dr. Gordon L. Amidon received his B.S. degree from the State University of New York, Buffalo (1967), an M.A. degree in Mathematics (1970) and Ph.D. in Pharmaceutical Chemistry (1971) from The University of Michigan.  From 1971 to 1981 Dr. Amidon was a member of the faculty at the University of Wisconsin. He was appointed Professor of Pharmaceutics at The University of Michigan in 1983 and was named the Charles R. Walgreen, Jr., Professor of Pharmacy in 1994. Dr. Amidon is internationally known for his research in the field of drug absorption, transport phenomena, solubility and dissolution, and prodrugs. He has published extensively in journals, with over 320 published papers and 370 abstracts, 18 US patents, contributed chapters to over 30 books and monographs and is co-editor of eight books.  Professor Amidon has mentored over 80 doctoral and postdoctoral students with more than 20 selecting academic careers. He has received numerous awards including; best paper awards in the Journal of Pharmaceutical Sciences (1975, 1981, 1984) and Pharmaceutical Research (2004); the Scheele Award of the Swedish Academy of Pharmaceutical Sciences for outstanding contributions to the field of oral drug delivery and biopharmaceutics (1996). He received an honorary Doctor of Pharmacy degree from the University of Uppsala, Sweden (2001); the Founders Award of the Controlled Release Society (2003); the Volwiler Award of the American Association of Colleges of Pharmacy (2004); the AAPS Distinguished Pharmaceutical Scientist Award (2005); the FIP Distinguished Pharmaceutical Scientist Award (2006), the Gerhard Levy Distinguished Lectureship (2006), the Alexander von Humboldt Research Award (2009) and the Japan Society for the Promotion of Science (JSPS) Fellowship Award (2011). He has organized and participated in many international symposia and workshops. Dr. Amidon developed a Biopharmaceutics Classification System (BCS), with the FDA, impacting bioequivalence standards worldwide. He is a Fellow of the AAPS, APhA/APS, and the AAAS. He is a member of the Controlled Release Society, serving as president in 1994, AACP, ACS and AAPS, serving as president in 1998. Dr. Amidon is the editor of the American Chemical Society Journal, Molecular Pharmaceutics.  He is the Co-Director of the Center for Molecular Drug Targeting, The University of Michigan, College of Pharmacy.

 


Maria del Val (Marival)  Bermejo

Full Professor

Universidad Miguel Hernández de Elche

Alicante, España

Marival Bermejo is currently Full Professor at the University Miguel Hernández of Elche-Alicante (Spain). She earned her PharmD and Ph.D degrees at the University of Valencia under the supervision of Prof. Plá-Delfina with a grant from Spanish Government. She got a position at the University of Valencia as Assistant Professor in 1993 and was promoted to Associate Professor in 1998. In 2008 she was appointed at University Miguel Hernández to coordinate the Area of Pharmacy and Pharmaceutical Technology in the Department of Engineering. She performed two post-doctoral research stages at the Institute of Topology and System Dynamics in Paris VII University, collaborating with Prof. Christiane Mercier and at the University of Michigan, working with Prof. Gordon Amidon. Dr. Bermejo research was centered on intestinal absorption. Her last research projects have been focused on the validation of in situ and in vitro models for oral permeability predictions and blood-brain-barrier permeation and their application to the biopharmaceutical development of new drugs.  Marival Bermejo is member of the “BIOSIM Network of Excellence” and she is the coordinator of the Alpha III project “Red Biofarma”, both funded by the European Commission and devoted to the improvement of in vitro methods for drug absorption predictions and the use of modeling and simulation as tools in drug development. She has been co-author of 73 papers, 10 books chapters and is co-author along with Gordon Amidon of the English and Spanish versions of Modern Biopharmaceutics, a CD-Rom teaching tool. In 2001 her team was awarded with the Research Prize of “Liconsa-Chemo Ibérica” for their work on fluoroquinolones absorption. She is member of the Board of Directors of the Drug Delivery Foundation (www.ddfint.org) and external assessor of the Spanish Agency of Medicines (AGEMED) and EMEA (European Medicines Agency). Dr Bermejo has been recently nominated as a foreign member of the Chilean Academy of Sciences. She has been awarded with a Fulbright scholarship for a 4-month sabbatical period at the University of Michigan in 2015 working on in vivo predictive dissolution with Prof. Gordon Amidon as local host. In 2016 Dr Bermejo spent 3 months at Prof. Amidon’s laboratory as Visiting Research Scientist.